Cargando…
Effective combinatorial immunotherapy for penile squamous cell carcinoma
Penile squamous cell carcinoma (PSCC) accounts for over 95% of penile malignancies and causes significant mortality and morbidity in developing countries. Molecular mechanisms and therapies of PSCC are understudied, owing to scarcity of laboratory models. Herein, we describe a genetically engineered...
Autores principales: | Huang, Tianhe, Cheng, Xi, Chahoud, Jad, Sarhan, Ahmed, Tamboli, Pheroze, Rao, Priya, Guo, Ming, Manyam, Ganiraju, Zhang, Li, Xiang, Yu, Han, Leng, Shang, Xiaoying, Deng, Pingna, Luo, Yanting, Lu, Xuemin, Feng, Shan, Ferrer, Magaly Martinez, Alan Wang, Y., DePinho, Ronald A., Pettaway, Curtis A., Lu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195486/ https://www.ncbi.nlm.nih.gov/pubmed/32358507 http://dx.doi.org/10.1038/s41467-020-15980-9 |
Ejemplares similares
-
Prognostic Significance of p16 and Its Relationship with Human Papillomavirus Status in Patients with Penile Squamous Cell Carcinoma: Results of 5 Years Follow-Up
por: Chahoud, Jad, et al.
Publicado: (2022) -
Effective Combinatorial Immunotherapy for Castration Resistant Prostate Cancer
por: Lu, Xin, et al.
Publicado: (2017) -
An update on treatment of penile cancer
por: Chadha, Juskaran, et al.
Publicado: (2022) -
Penile cancer: Updates in systemic therapy
por: Joshi, Vidhu B., et al.
Publicado: (2022) -
The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma—A Systematic Review
por: Parza, Kevin, et al.
Publicado: (2023)